Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
LetterLetters

Critical Illness Related Pneumonia Rather Than Ventilator-Associated Pneumonia (VAP)The authors respond:

Durk Freark Zandstra, Steven Deem, Andy J Petros, Luciano Silvestri, Hendrik KF van Saene, Nia Taylor and Miriam M Treggiari
Respiratory Care February 2012, 57 (2) 329-330; DOI: https://doi.org/10.4187/respcare.01561
Durk Freark Zandstra
Department of Intensive Care Onze Lieve Vrouwe Gasthuis Hospital Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Deem
Anesthesiology Department Harborview Medical Center University of Washington Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy J Petros
Department of Intensive Care Great Ormond Street Children's Hospital London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Silvestri
Department of Anesthesia and Intensive Care Gorizia Regional Hospital Gorizia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik KF van Saene
Institute of Ageing and Chronic Diseases University of Liverpool Liverpool, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nia Taylor
Institute of Ageing and Chronic Diseases University of Liverpool Liverpool, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam M Treggiari
Anesthesiology Department Harborview Medical Center University of Washington Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

We read with interest the review article entitled “New endotracheal tubes designed to prevent ventilator-associated pneumonia: do they make a difference?” by Deem and Treggiari.1 In line with European experts,2 the American researchers state that “the high VAP rate in ventilated patients is probably due to factors associated with translaryngeal intubation rather than simply an effect of patient susceptibility from severity of illness.” We disagree with this expert opinion and we would argue that the severity of underlying disease is the major determinant of developing pneumonia in patients requiring treatment on the intensive care unit (ICU).3 Our statement that “the sicker the patients, the higher the pneumonia rate” is supported by the following quantitative data. The incidence of hospital-acquired pneumonia is approximately 5-10 per 1,000 admissions.3,4 The pneumonia rate is 7% in patients requiring treatment on ICU without endotracheal intubation, and increases to 12% in ICU patients requiring endotracheal intubation.3,4 The pneumonia rate is lower with noninvasive ventilation (1.58 per 1,000 ventilator days), compared with invasive ventilation (5.44 per 1,000 ventilator days).5 Remarkably, the patients receiving noninvasive ventilation were less ill than the ones who were endotracheally intubated. Finally, a recent epidemiological study on the prevalence and outcomes of infection in ICUs showed that the infection rate was related to disease severity assessed by the Simplified Acute Physiology Score II.6

Apart from illness severity, the abnormal oropharyngeal carrier state is a higher risk factor than the endotracheal tube. It is generally acknowledged that underlying disease promotes the abnormal oropharyngeal carrier state.7 Less known is that the presence of the nasogastric tube is another factor that promotes abnormal oropharyngeal carriage.8

Deem and Treggiari acknowledge that selective decontamination of the digestive tract (SDD) is an effective VAP prevention technique, referring to one of the first Italian meta-analyses in 1998.9 They fail to mention the most recent Cochrane meta-analysis of randomized controlled trials of SDD from 2009, demonstrating that SDD reduces VAP by 72% (odds ratio 0.28, 95% CI 0.20-0.38).10 As 2 of the originators of SDD, we would suggest that the efficacy of SDD is due to the control of gut overgrowth associated with critical illness.11 Gut overgrowth harms the critically ill in 4 main ways. Overgrowth of “abnormal” aerobic Gram-negative bacilli and/or endotoxin has been shown to cause inflammation, immunosuppression, infection, and antimicrobial resistance. SDD is a prophylactic measure using selected antimicrobials to control gut overgrowth, thereby reducing the 4 harmful side effects, including restoration of suppressed systemic immunity and reduction of severe infections of lower airways.

In conclusion, severity of underlying disease promoting oropharyngeal overgrowth and subsequent lower airway infection following migration is the major determinant factor for developing pneumonia, rather than factors associated with translaryngeal intubation.

  • © 2012 by Daedalus Enterprises Inc.

References

  1. 1.↵
    1. Deem S,
    2. Treggiari MM
    . New endotracheal tubes designed to prevent ventilator-associated pneumonia: do they make a difference? Respir Care 2010;55(8):1046–1055.
    OpenUrlPubMed
  2. 2.↵
    1. Torres A,
    2. Ewig S,
    3. Lode H,
    4. Carlet J,
    5. for the European HAP working group
    . Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009;35(1):9–29.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Fagon JY,
    2. Chastre J,
    3. Hance AJ,
    4. Montravers P,
    5. Novara A,
    6. Gibert C
    . Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94(3):281–288.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement of the American Thoracic Society. Am J Respir Crit Care Med 1995;153(5):1711–1725.
    OpenUrl
  5. 5.↵
    1. Kohlenberg A,
    2. Schwab F,
    3. Behnka M,
    4. Geffers C,
    5. Gastmeier P
    . Pneumonia associated with invasive and non-invasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med 2010;36(6):971–978.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Vincent JL,
    2. Rello J,
    3. Marshall J,
    4. Silva E,
    5. Anzueto A,
    6. Martin CD,
    7. et al
    . International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(2):2323–2329.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dal Nogare AR,
    2. Toews GB,
    3. Pterce AK
    . Increased salivary elastase precedes Gram-negative bacillary colonisation in postoperative patients. Am Rev Respir Dis 1987;135(3):671–675.
    OpenUrlPubMed
  8. 8.↵
    1. Wynne JW,
    2. Modell JH
    . Respiratory aspiration of stomach contents. Ann Intern Med 1977;87(4):466–471.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. D'Amico R,
    2. Pifferi S,
    3. Leonetti C,
    4. Torri V,
    5. Tinazzi A,
    6. Liberati A
    . Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316(7140):1275–1285.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Liberati A,
    2. D'Amico R,
    3. Pifferi S,
    4. Torri V,
    5. Brazzi L,
    6. Parmelli E
    . Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009 (4); CD000022.
  11. 11.↵
    1. Petros A,
    2. Taylor N,
    3. van Saene HKF,
    4. Silvestri L
    . Gut overgrowth harms the critically ill (letter). Intensive Care Med 2011;37(9):1560.
    OpenUrlPubMed

The authors respond:

330 331

We appreciate the interest that Zandstra and colleagues have shown in our review of “New endotracheal tubes designed to prevent ventilator-associated pneumonia.” We agree with Zandstra et al that severity of illness is an important risk factor for the development of ventilator-associated pneumonia (VAP). However, we stand by our original statement that VAP “is probably due to factors associated with translaryngeal intubation.” This is borne out by the nearly 50% reduction in VAP associated with subglottic secretion drainage,1 polyurethane-cuffed tracheal tubes,2 and a variety of other interventions designed to either reduce microaspiration or the bacterial burden of aspirated oropharyngeal secretions.3,4 The general decline in VAP rates over the past 5 years, as reported by the Center for Disease Control (CDC), and in association with widespread implementation of “VAP bundles” also supports the notion that VAP is a modifiable event. Zandstra and colleagues make this case very cogently in their argument for selective decontamination of the digestive track as a VAP-preventive measure.

References

  1. 1.↵
    1. Muscedere J,
    2. Rewa O,
    3. McKechnie K,
    4. Jiang X,
    5. Laporta D,
    6. Heyland DK
    . Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med 2011;39(8):1985–1991.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Poelaert J,
    2. Depuydt P,
    3. De Wolf A,
    4. Van de Velde S,
    5. Herck I,
    6. Blot S
    . Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: a pilot study. J Thorac Cardiovasc Surg 2008;135(4):771–776.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Chlebicki MP,
    2. Safdar N
    . Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007;35(2):595–602.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Drakulovic MB,
    2. Torres A,
    3. Bauer TT,
    4. Nicolas JM,
    5. Nogue S,
    6. Ferrer M
    . Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354(9193):1851–1858.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Respiratory Care: 57 (2)
Respiratory Care
Vol. 57, Issue 2
1 Feb 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Critical Illness Related Pneumonia Rather Than Ventilator-Associated Pneumonia (VAP)The authors respond:
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Critical Illness Related Pneumonia Rather Than Ventilator-Associated Pneumonia (VAP)The authors respond:
Durk Freark Zandstra, Steven Deem, Andy J Petros, Luciano Silvestri, Hendrik KF van Saene, Nia Taylor, Miriam M Treggiari
Respiratory Care Feb 2012, 57 (2) 329-330; DOI: 10.4187/respcare.01561

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Critical Illness Related Pneumonia Rather Than Ventilator-Associated Pneumonia (VAP)The authors respond:
Durk Freark Zandstra, Steven Deem, Andy J Petros, Luciano Silvestri, Hendrik KF van Saene, Nia Taylor, Miriam M Treggiari
Respiratory Care Feb 2012, 57 (2) 329-330; DOI: 10.4187/respcare.01561
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire